CN106177757A - A kind of Chinese medicine treating syndrome of remained toxicity type maxillofacial sore disease - Google Patents
A kind of Chinese medicine treating syndrome of remained toxicity type maxillofacial sore disease Download PDFInfo
- Publication number
- CN106177757A CN106177757A CN201610607980.0A CN201610607980A CN106177757A CN 106177757 A CN106177757 A CN 106177757A CN 201610607980 A CN201610607980 A CN 201610607980A CN 106177757 A CN106177757 A CN 106177757A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- remained
- disease
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine treating syndrome of remained toxicity type maxillofacial sore disease, it is characterized in that the Chinese medicine preparation being made up of the medical material of following weight proportion: Fructus Forsythiae 18 20 parts, Spica Prunellae 20 25 parts, Fructus Gardeniae 20 25 parts, Radix Scutellariae 30 32 parts, Flos Lonicerae 38 40 parts, Rhizoma Phragmitis 12 15 parts, Radix Scrophulariae 28 30 parts, Rhizoma Curcumae 15 18 parts, Radix Angelicae Sinensis 22 25 parts, Folium Hibisci Mutabilis 12 15 parts.Any of the above raw material is organically combined by the present invention, mutually coordinated between each composition, interacts, treating both the principal and secondary aspects of a disease enough to syndrome of remained toxicity type maxillofacial sore condition of disease, and has good opsonic action to health.For many years, by the follow-up investigation of 50 these type of patients of example is added up, show that this prescription cure rate reaches 82%.
Description
Present disclosure relates to a kind of Chinese medicine, a kind of Chinese medicine treating syndrome of remained toxicity type maxillofacial sore disease.
After background technology maxillofacial sore disease refers to febrile disease, residual poison knot gathers the acute festering type disease between chin or cheek jaw.It is more common in
Adult.Pain have tension from the beginning of between chin or cheek jaw, slight swelling, slightly difficulty of dehiscing.Continuing, swelling gradually aggravates and extends to
Before and after ear.After dehiscing, it is seen that red and swollen orifice of parotid duct, if compressing local, purulent secretion is had to overflow from mouth of pipe opening part.About
Within 7 10 days, entering people and become the pus phase, now the pain increased, and in jumping pain, color of the leather is rubescent, and swelling more very, can involve homonymy eyelid, cheek
, there is fluctuation in portion, cervical region etc. by it.Parotid duct opening part can extrude cloudy yellow purulent secretion simultaneously.Master of the present invention
To be studied is, and clinical common syndrome of remained toxicity type maxillofacial sore is sick, and this pattern of syndrome system is because of sweating is not smooth after typhoid fever or epidemic febrile disease, so that remaining
Pathogenic heat poison reaches outside failing, and knot gathers in meridians, and coagulation of QI-blood is in local, and slough becomes pus to cause.It is often accompanied by foul smelling in mouth, yellow and thin fur
Or greasy, the symptom such as rolling pulse.At present, this disease of western medical treatment takes to take the mode of antibiotics more, cures the symptoms, not the disease, secondary work
With greatly, and easily form dependency.
Summary of the invention it is an object of the invention to according to " heat-clearing and toxic substances removing, blood stasis-eliminating and stagnation-dissipating " Therapeutic Principle, it is provided that one can be controlled
Treat the Chinese medicine that syndrome of remained toxicity type maxillofacial sore is sick, use this Chinese medicine not only to cure speed soon, can not be relapsed after the healing, and without any pair
Effect, also has good opsonic action to healthy.
For realizing the above-mentioned purpose of the present invention, it is sick that the technical scheme is that one treats syndrome of remained toxicity type maxillofacial sore
Chinese medicine, it is characterized in that the Chinese medicine preparation being made up of the medical material of following weight proportion: Fructus Forsythiae 18 20 parts, Spica Prunellae 20 25
Part, Fructus Gardeniae 20 25 parts, Radix Scutellariae 30 32 parts, Flos Lonicerae 38 40 parts, Rhizoma Phragmitis 12 15 parts, Radix Scrophulariae 28 30 parts, Rhizoma Curcumae
15 18 parts, Radix Angelicae Sinensis 22 25 parts, Folium Hibisci Mutabilis 12 15 parts.The processing technique of the present invention is: various medical material grindings are become end,
Then extract by conventional method " whole part " and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, Yu Yin
Cool, the place of being dried preserves.Dissolving with boiled water after meal and take, having part insoluble matter is normal phenomenon, under all taking after mixing, and one day two
Secondary (the most once), each one bag, 7 days be a course for the treatment of.Taking medicine period, suitable diet is light, avoids tobacco and wine, raw meat, food cold, peppery
Thing, notes oral hygiene, strengthens mouth care, and the work and rest keeping good is accustomed to, association's rationally decompression, actively participates in outdoor fortune
Dynamic, loosen mood, avoid staying up late as far as possible.
Fructus Forsythiae of the present invention has heat-clearing and toxic substances removing, dispelling wind and heat pathogens, dispersing swelling and dissipating binds, the effect of the diuresis that clears away heart-fire；Use
Spica Prunellae there is clearing away heat-fire, improving eyesight, effect of mass dissipating and swelling eliminating；The Fructus Gardeniae used has pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, removing heat from blood
Removing toxic substances, effect of reducing swelling and alleviating pain；The Radix Scutellariae used has heat clearing and damp drying, eliminating fire and detoxication, cooling blood for hemostasis, heat extraction is antiabortive, antiinflammatory is anti-
Effect of bacterium；The Flos Lonicerae used has effect of heat-clearing and toxic substances removing, dispelling wind and heat pathogens, removing heat from blood；Use Rhizoma Phragmitis have clearing away heat and promoting production of body fluid,
Clearing stomach relieves restlessness and prevents vomiting, evacuation of pus of eliminating the phlegm, effect of diuresis rash；The Radix Scrophulariae used has clearing away heat and cooling blood, Yin-nourishing and body fluid promoting, pathogenic fire purging solution
Poison, effect of dispersing swelling and dissipating binds；The Rhizoma Curcumae used has removing blood stasis circulation of qi promoting, effect of removing food stagnancy pain relieving；Use Radix Angelicae Sinensis have enrich blood foster
Blood, promoting blood circulation to remove blood stasis, regulating menstruation, pain relieving, effect of intestine moistening；The Folium Hibisci Mutabilis used have removing heat from blood, detoxify, subside a swelling, effect of pain relieving.
Any of the above raw material is organically combined by the present invention, mutually coordinated between each composition, interacts, to syndrome of remained toxicity
The enough treating both the principal and secondary aspects of a disease of type maxillofacial sore condition of disease, and health is had good opsonic action.For many years, by the tracking to 50 these type of patients of example
Investigation statistics, shows that this prescription cure rate reaches 82%.
Below by the basic condition analysis about data, further illustrate the effect of the present invention.
General patient demographic's structure and Cure
| Age group (year) | Case load | Occupation | Case load | Healing number | Cure rate |
| 18—25 | 6 people | Workman | 7 people | 6 people | 86% |
| 26--30 | 7 people | Businessman | 9 people | 6 people | 67% |
| 31--35 | 11 people | Cadre | 8 people | 7 people | 88% |
| 36--40 | 10 people | Peasant | 12 people | 10 people | 83% |
| >40 | 16 people | Other | 14 people | 12 people | 86% |
| Add up to | 50 people | Add up to | 50 people | 41 people | 82% |
Enumerate three model cases below and further illustrate the effect of the present invention:
1, Liu, birth in 1972, when 40 years old, occur that chin or cheek jaw portion swells and ache, recurrent exerbation symptom, with stench in mouth.Yellow and thin fur,
The symptoms such as rolling pulse, without organic disease, after be diagnosed as syndrome of remained toxicity type maxillofacial sore in here sick.After taking 1 course for the treatment of of this prescription,
Remission, after taking 1 course for the treatment of, symptom is clearly better, after continue to take and consolidate 1 course for the treatment of after, symptom disappears entirely, recovery from illness.
2, shutting out certain, birth in 1966, when 45 years old, when there is feed, chin or cheek jaw portion feels distending pain, and that touches seemingly has streak thing disease
Shape, with symptoms such as mouth frowziness, tongue fur BOHUANG, rolling pulse, without organic disease, after be diagnosed as syndrome of remained toxicity type in here and send out
Chin or cheek disease, after taking 1 course for the treatment of of this prescription, symptom has been alleviated, and after 2 courses for the treatment of, symptom disappears entirely, recovery from illness.
3, Zhao, birth in 1988, when 24 years old, occur that chin or cheek jaw portion swells and ache, orifice of parotid duct can extrude purulent secretion symptom,
With symptoms such as mouth frowziness, yellowish fur, rolling pulse, after be diagnosed as syndrome of remained toxicity type maxillofacial sore in here sick, take this prescription 1
After the individual course for the treatment of, symptom is substantially alleviated, and after 2 courses for the treatment of, symptom disappears substantially, after continue again to take 1 course for the treatment of and consolidate, symptom
Entirely disappear, recovery from illness.
The present invention, for describing the present invention in detail, is done the most in detail by detailed description of the invention below in conjunction with specific embodiment
Description.
Embodiment 1: Fructus Forsythiae 18 grams, Spica Prunellae 20 grams, Fructus Gardeniae 20 grams, Radix Scutellariae 30 grams, Flos Lonicerae 38 grams, Rhizoma Phragmitis 12 grams, profound
Join 28 grams, Rhizoma Curcumae 15 grams, Radix Angelicae Sinensis 22 grams, Folium Hibisci Mutabilis 12 grams.Any of the above medical material grinding is become end, then uses conventional method
" whole part " extracts and makes instant Chinese medicine granule, carries out subpackage according to every pouch 10 grams, airtight, preserves in shady and cool, the place of being dried.
Embodiment 2: Fructus Forsythiae 19 grams, Spica Prunellae 22 grams, Fructus Gardeniae 22 grams, Radix Scutellariae 31 grams, Flos Lonicerae 39 grams, Rhizoma Phragmitis 13 grams, profound
Join 29 grams, Rhizoma Curcumae 17 grams, Radix Angelicae Sinensis 23 grams, Folium Hibisci Mutabilis 13 grams.Any of the above medical material grinding is become end, then uses conventional method
" whole part " extracts and makes instant Chinese medicine granule, carries out subpackage according to every pouch 10 grams, airtight, preserves in shady and cool, the place of being dried.
Embodiment 3: Fructus Forsythiae 20 grams, Spica Prunellae 25 grams, Fructus Gardeniae 25 grams, Radix Scutellariae 32 grams, Flos Lonicerae 40 grams, Rhizoma Phragmitis 15 grams, profound
Join 30 grams, Rhizoma Curcumae 18 grams, Radix Angelicae Sinensis 25 grams, Folium Hibisci Mutabilis 15 grams.Any of the above medical material grinding is become end, then uses conventional method
" whole part " extracts and makes instant Chinese medicine granule, carries out subpackage according to every pouch 10 grams, airtight, preserves in shady and cool, the place of being dried.
Claims (1)
1. treat the Chinese medicine that syndrome of remained toxicity type maxillofacial sore is sick, it is characterized in that the Chinese medicine being made up of the medical material of following weight proportion
Preparation: Fructus Forsythiae 18 20 parts, Spica Prunellae 20 25 parts, Fructus Gardeniae 20 25 parts, Radix Scutellariae 30 32 parts, Flos Lonicerae 38 40 parts, reed
Root 12 15 parts, Radix Scrophulariae 28 30 parts, Rhizoma Curcumae 15 18 parts, Radix Angelicae Sinensis 22 25 parts, Folium Hibisci Mutabilis 12 15 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610607980.0A CN106177757A (en) | 2016-07-29 | 2016-07-29 | A kind of Chinese medicine treating syndrome of remained toxicity type maxillofacial sore disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610607980.0A CN106177757A (en) | 2016-07-29 | 2016-07-29 | A kind of Chinese medicine treating syndrome of remained toxicity type maxillofacial sore disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106177757A true CN106177757A (en) | 2016-12-07 |
Family
ID=57495948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610607980.0A Pending CN106177757A (en) | 2016-07-29 | 2016-07-29 | A kind of Chinese medicine treating syndrome of remained toxicity type maxillofacial sore disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106177757A (en) |
-
2016
- 2016-07-29 CN CN201610607980.0A patent/CN106177757A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| WMR2045: "【精品】中医外科学", 《HTTP://WWW.DOC88.COM/P-7496114123646.HTML》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104288477A (en) | Traditional Chinese medicine preparation curing infantile asthma | |
| CN104225291A (en) | Traditional Chinese medicine for treating intermenstrual aphthous stomatitis due to yin-deficiency and fire-hyperactivity syndromes | |
| CN106177757A (en) | A kind of Chinese medicine treating syndrome of remained toxicity type maxillofacial sore disease | |
| CN104107344A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN104491460B (en) | A kind of Traditional Chinese medicine liniment for the treatment of oral ulcer | |
| CN106109897A (en) | A kind of Chinese medicine treating syndrome of interior invaded by heat-toxicity type maxillofacial sore disease | |
| CN104367826A (en) | Traditional Chinese medicine for treating ischogalactia acute mastitis caused by milk stasis syndrome | |
| CN106038815A (en) | Traditional Chinese medicine for treating toxin predominance pyogenesis syndrome type parotitis phlegmonosa | |
| CN105343364A (en) | Traditional Chinese medicine for treating fire toxin accumulation syndrome type palate carbunculosis | |
| CN106177218A (en) | A kind of pyretic toxicity for the treatment of pents up the Chinese medicine that pattern of syndrome maxillofacial sore is sick | |
| CN104225189A (en) | Traditional Chinese medicine for treating intermenstrual aphthous stomatitis due to stomach-heat fumigation syndrome | |
| CN105327324A (en) | Traditional Chinese medicine for treating cold-evil internal amassment type abdominal pain | |
| CN104225107B (en) | Traditional Chinese medicine for treating liver Qi stagnation type globus hysteriocus | |
| CN104398596A (en) | Traditional Chinese medicinal formula for treating oral ulcer | |
| CN104367660B (en) | A kind of Chinese medicine treating phlegm-damp stasis pattern of syndrome abdominal mass | |
| CN105998271A (en) | Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease | |
| CN107854559A (en) | A kind of Chinese medicine for treating pharyngitis | |
| CN105477141A (en) | Traditional Chinese medicine for treating palate carbuncle due to yang-ming fu-viscera excess | |
| CN105998904A (en) | Traditional Chinese medicine for treating spleen-and-stomach-heat-accumulating-syndrome-type gingival atrophy disease | |
| CN105998663A (en) | Traditional Chinese medicine for treating deficiency fire tonsillitis with lung-yin deficiency syndrome | |
| CN104147482A (en) | Traditional Chinese medicine (TCM) for treating chronic pelvic inflammatory diseases caused by qi deficiency and blood stasis | |
| CN106038980A (en) | Traditional Chinese medicine for treating yin deficiency and exuberant fire type inguinal carbuncle | |
| CN104435811A (en) | Traditional Chinese medicine for treating gastrointestinal diseases caused by stomach-yin deficiency | |
| CN106110246A (en) | A kind of heresy for the treatment of enters the Chinese medicine that shaoyang disease type invasion of the blood-chamber by heat is sick | |
| CN106109734A (en) | A kind of heat-damp in summer for the treatment of hands over the Chinese medicine of resistance pattern of syndrome multiple abscess disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161207 |